SBI Life Insurance Company Ltd
NSE: SBILIFECompany page on Cofacto
Open the SBI Life Insurance Company Ltd page

SBI Life Insurance Company Limited (SBILIFE) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Cofacto Research Published October 22, 2026 5 min read
Quick Details
Results dateOctober 27, 2026
QuarterQ2 FY 2026-2027
Previous quarter revenueNet Premium Income Rs. 20,078.21 Cr (+16.88% YoY)
Previous quarter PATRs. 724.93 Cr (+21.97% YoY)
Previous quarter VoNB margin26.2%
Market capRs. 166,475.49 Cr
CMPRs. 1,658.0

SBI Life Insurance Company Limited Q2 Results Date and Time

The board will meet on Tuesday, October 27, 2026, to approve the audited financial results for the quarter and half year ended September 30, 2026. The trading window has been closed since October 1, 2026, and reopens 48 hours after the results declaration.

At the 26th AGM held via video conference on August 14, 2026, shareholders confirmed the interim dividend declared on February 25, 2026 as the final dividend for FY26. The per-share dividend amount was not disclosed in the company's filings.

What to expect from SBI Life Insurance Company Limited's Q2 FY27 results

The quarter's central test is whether the VoNB margin, which bottomed out at 26.2% in Q1 FY27, re-enters the upper half of the guided 26-28% band as the one-off group/GTI mix that took 60 bps off Q1 fades. Industry new-business flow stayed robust through the quarter — NBP up 20.7% YoY in July, 33.07% in August and 21.32% in September — but growth was concentrated in low-margin group single premium, and SBI Life's own monthly prints cooled to +9% total APE in July and +2% NBP in September, making the 14% FY27 APE guidance dependent on banca re-acceleration and the J&K Bank tie-up commencing in Q2. On costs, the residual GST drag is guided to shrink from the 1.1% hit in Q1 before full mitigation by 3QFY27, while the opex ratio of 7.7% and total cost ratio of 12.0% in Q1 are expected to streamline over the next three quarters per management. Investment conditions turned less friendly through the quarter — the 10-year G-sec yield hardened about 30 bps to 7.05% by September 21 and the Nifty closed below 23,150 on September 15 with FII outflows of Rs. 44,013 cr — pointing to a softer equity-variance contribution than Q1's +2.15% EV boost. The call should also cover the deferred annuity launch committed for this quarter, the status of the appeal against the Rs. 1.13 Cr GST demand order, and management's first read on the IRDAI proposal to cap credit-life single-premium commissions at 2%.

Key Things To Watch

VNB margin vs the 26-28% guidance band: Q1 printed 26.2% against a 27.4% year-ago quarter, with management guiding toward the upper end as mix normalizes.

  • Whether Q2 margin re-enters the upper half of the 26-28% band against the 27.8% H1 FY26 base
  • How many bps of residual GST drag remain in Q2 versus the 1.1% drag in Q1, with full mitigation guided by 3QFY27
  • How much of the one-time group/GTI mix (25% of Q1 APE vs a typical 10-12%) fades from the quarter's business

APE trajectory vs the 14% FY27 growth target

  • Whether individual-led growth sustains after July total APE slowed to +9% YoY and September NBP grew just 2% to Rs. 4,035.17 Cr
  • Banca re-acceleration commentary — SBI channel grew ~10% in Q1 while other banks grew 19% on Individual NBP and 31% on APE
  • J&K Bank corporate agency business, expected to commence in Q2 FY27 — seek commencement and pipeline updates

Product launches and credit-protect uptick

  • Deferred annuity launch status — committed 'within the next quarter' as of the July 24, 2026 call
  • Credit protect business — management flagged an expected uptick 'in coming quarters' after flat Q1 growth

Cost ratios, persistency and regulatory markers

  • Opex and total cost ratios against the 'same range plus minus' commitment as the Rs. 135 crores labour-code and stamp-duty pressures streamline over the next three quarters
  • 61st-month persistency at 58.4% vs 63.6% — whether the COVID-cohort explanation holds and recovery materializes as predicted
  • Updates on the RBI open-architecture draft for banks, the appeal against the Rs. 1.13 Cr GST demand order (Section 74, RGST Act 2017), and the IRDAI proposal to cap credit-life single-premium commissions at 2%

Operating metric trajectory: Q1 FY27 operating metrics showed broad-based improvement outside one cohort.

  • 13M persistency improved 61 bps to 87.7% and 49M improved 68 bps to 69.1% in Q1 FY27
  • Protection APE grew 208% YoY to Rs. 14.3 billion (27% of Q1 APE), with pure protection up 52% within individual protection
  • Agency APE grew 24% and the Others channel grew 160% in Q1, while bancassurance grew 10% to Rs. 25.5 bn (47% of APE)

Frequently Asked Questions

Why did SBI Life's VNB margin fall in Q1 FY27?

The VoNB margin slipped to 26.2% from 27.4% a year ago, with 40 bps from operating assumption changes at the March 2026 annual review and 60 bps from one-time group term insurance (GTI) business carrying a lower margin. Management said individual margins excluding group business improved significantly and that margins have bottomed out in Q1.

Is SBI Life on track with its FY27 guidance?

Management has guided to 14% APE growth and a 26-28% VNB margin for FY27, with margins expected to move toward the upper end of the band as product mix normalizes. Q1 FY27 APE grew 36% YoY on a group-heavy mix, though monthly prints cooled thereafter, with July total APE up 9% and September NBP up 2%.

What is the GST demand order against SBI Life?

The company received a GST demand of Rs. 1,12,99,508 (about Rs. 1.13 Cr) dated September 25, 2026 under Section 74 of the RGST Act 2017, relating to excess input tax credit for April-August 2025. SBI Life is filing an appeal against the order.

When will SBI Life launch its new deferred annuity plan?

As of the July 24, 2026 call, the new regular-pay deferred annuity plan was expected to launch within the next quarter. The product had earlier been committed for launch by Q1 or Q2 of the current fiscal year.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now